title: Combined chemotherapy, radiotherapy and surgery in inflammatory breast carcinoma.
authors.affiliation: Department of Radiation Oncology, Hospital General Vall d'Hebron, University of Barcelona, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Vergés
authors.forename: E
authors.initials: E
authors.lastname: Felip
authors.forename: I
authors.initials: I
authors.lastname: Alastuey
authors.forename: F
authors.initials: F
authors.lastname: Capdevila
authors.forename: Z
authors.initials: Z
authors.lastname: Maldonado
authors.forename: R
authors.initials: R
authors.lastname: Bodi
authors.forename: J
authors.initials: J
authors.lastname: Giralt
authors.forename: L
authors.initials: L
authors.lastname: Salvador
mesh_terms: D000230:Adenocarcinoma / Q000628:therapy*; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000628:therapy*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008408:Mastectomy; D008875:Middle Aged; D011446:Prospective Studies; D011879:Radiotherapy Dosage; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D004317:Doxorubicin; D003520:Cyclophosphamide